These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4575393)

  • 21. Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis.
    Martins M; Lazzell AL; Lopez-Ribot JL; Henriques M; Oliveira R
    J Basic Microbiol; 2012 Aug; 52(4):487-91. PubMed ID: 22052380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Hwp2, a Candida albicans putative GPI-anchored cell wall protein necessary for invasive growth.
    Hayek P; Dib L; Yazbeck P; Beyrouthy B; Khalaf RA
    Microbiol Res; 2010 Mar; 165(3):250-8. PubMed ID: 19616419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The correlation of virulence, pathogenicity, and itraconazole resistance with SAP activity in Candida albicans strains.
    Feng W; Yang J; Pan Y; Xi Z; Qiao Z; Ma Y
    Can J Microbiol; 2016 Feb; 62(2):173-8. PubMed ID: 26751517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revelations about Candida albicans, a bundle of letters from our readers, and an assault on breastfeeding.
    Lawrence RA
    Breastfeed Med; 2009 Jun; 4(2):55. PubMed ID: 19500048
    [No Abstract]   [Full Text] [Related]  

  • 25. [PATHOGENICITY OF STRAINS OF CANDIDA ALBICANS].
    SANDULA J; KOCKOVA KRATOCHVILOV ; ZAMECNIKOVA M
    Biologia (Bratisl); 1963; 18():843-7. PubMed ID: 14114535
    [No Abstract]   [Full Text] [Related]  

  • 26. Exoenzyme activity and possibility identification of Candida dubliniensis among Candida albicans species isolated from vaginal candidiasis.
    Jafari M; Salari S; Pakshir K; Zomorodian K
    Microb Pathog; 2017 Sep; 110():73-77. PubMed ID: 28642006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.
    Navarathna DH; Hornby JM; Krishnan N; Parkhurst A; Duhamel GE; Nickerson KW
    Infect Immun; 2007 Apr; 75(4):1609-18. PubMed ID: 17283095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of phospholipase activity of Candida albicans and its correlation with pathogenicity in mice.
    Kothavade RJ; Panthaki MH
    J Med Microbiol; 1998 Feb; 47(2):99-102. PubMed ID: 9879950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of challenge with Candida albicans strains with different levels of virulence on plasma proteins in burned mice.
    Neely AN; Childress CM; Holder IA
    Infect Immun; 1991 Apr; 59(4):1576-8. PubMed ID: 2004833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental study and clinical application of rapid diagnosis of systemic candida albicans infection in burns by polymerase chain reaction].
    Deng G; Zhang Y; Xiao G
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1995 Sep; 11(5):323-6. PubMed ID: 8697241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.
    Asmundsdóttir LR; Erlendsdóttir H; Agnarsson BA; Gottfredsson M
    Clin Microbiol Infect; 2009 Jun; 15(6):576-85. PubMed ID: 19604278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The glyoxylate cycle enzyme activities in the pathogenic isolates of Candida albicans obtained from HIV/AIDS, diabetic and burn patients.
    Lattif AA; Prasad R; Banerjee U; Gupta N; Mohammad S; Baquer NZ
    Mycoses; 2006 Mar; 49(2):85-90. PubMed ID: 16466439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence and adhesive properties of serotypes A and B of Candida albicans isolated from paediatric burn patients.
    Kennedy MJ; Johnson AM; Volz PA; Neely AN; Yancey RJ
    J Med Microbiol; 1992 Jun; 36(6):428-36. PubMed ID: 1613783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of 5-hydroxytryptamine production by Candida albicans in vitro and in vivo.
    Hurley R; Leask BG; Ruthven CR; Sandler M; Southgate J
    Microbios; 1971 Sep; 4(14):133-43. PubMed ID: 4949965
    [No Abstract]   [Full Text] [Related]  

  • 35. Cecal colonization and systemic spread of Candida albicans in mice treated with antibiotics and dexamethasone.
    Bendel CM; Wiesner SM; Garni RM; Cebelinski E; Wells CL
    Pediatr Res; 2002 Mar; 51(3):290-5. PubMed ID: 11861932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candida albicans PLD I activity is required for full virulence.
    Dolan JW; Bell AC; Hube B; Schaller M; Warner TF; Balish E
    Med Mycol; 2004 Oct; 42(5):439-47. PubMed ID: 15552646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unilateral involvement of kidneys in mice infected with Candida albicans.
    Kwon-Chung KJ; Tom WK
    Sabouraudia; 1985 Feb; 23(1):81-3. PubMed ID: 3887605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of atypical lymphocytes following intravenous injection of Candida albicans in mice.
    Mankowski ZT
    Mycopathol Mycol Appl; 1971 Dec; 45(3):243-51. PubMed ID: 4365832
    [No Abstract]   [Full Text] [Related]  

  • 39. Phenotypic consequences of LYS4 gene disruption in Candida albicans.
    Gabriel I; Kur K; Laforce-Nesbitt SS; Pulickal AS; Bliss JM; Milewski S
    Yeast; 2014 Aug; 31(8):299-308. PubMed ID: 24898203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1.
    Gale CA; Bendel CM; McClellan M; Hauser M; Becker JM; Berman J; Hostetter MK
    Science; 1998 Feb; 279(5355):1355-8. PubMed ID: 9478896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.